TGA approves Pfizer booster for teens

Pfizer’s Comirnaty COVID-19 vaccine has been provisionally approved by the Therapeutic Goods Administration (TGA) for use as a booster in those aged 16–17 years.

What happens now we know the cardiovascular risk calculator was wrong

AP examines what the new cardiovascular risk calculator means for patients and whether the wrong people are on preventive medicines.

Best of the west: meet PSA’s newest award winners

Four pharmacists were crowned the best of the west at PSA’s West Australian Annual Therapeutic Update (ATU) last weekend.

Report any CAM adverse effects, warns Dr Geraldine Moses

Doctor of clinical pharmacy, consultant pharmacist and pharmacovigilance expert Geraldine Moses discusses the scary adverse effects of CAM.

How GP pharmacist medicine reviews prevent hospital readmissions

When under the care of a general practice pharmacist, patients recently discharged from hospital are far less likely to re-present, according to new research.

The trial that could revolutionise medicine safety

Rather than managing adverse events after the fact, the ACTmed trial helps pharmacists tackle medicine-related problems before they arise.